This invention is directed toward monoclonal antibodies that bind specifically to Notch1. In one embodiment, the antibodies binds to at least a first epitope and a second epitope, wherein the first epitope resides with the LinA domain of the NotchI negative regulatory region (NRR), and the second epitope resides within the HD-C domain of the Notch1 NRR.